Online citations, reference lists, and bibliographies.
← Back to Search

Mechanisms Of Cytopenia In Human Immunodeficiency Virus Infection.

A. Harbol, J. Liesveld, P. Simpson-Haidaris, C. Abboud
Published 1994 · Biology, Medicine

Save to my Library
Download PDF
Analyze on Scholarcy
Share
Human immunodeficiency virus (HIV) infection often has effects on the hematopoietic system which can be distinguished from the concurrent effects of medications or opportunistic infections. Exactly how the virus mediates these effects remains uncertain, but both in vivo and in vitro studies have pointed up possible direct and indirect modes of hematopoietic suppression. Whether a significant fraction of CD34+ cells in vivo are infected with HIV remains controversial, but most studies using in situ polymerase chain reaction techniques would suggest not. Other more indirect modes of hematopoietic cell suppression such as production of autoantibodies, production of other humoral inhibitory factors, T-cell mediated suppression of hematopoiesis, or production of inhibitory or stimulatory cytokines may also be contributory. It is probable that several of these mechanisms may occur simultaneously, and an increased understanding of their role may lead to improved strategies to correct the cytopenias which often accompany HIV disease.
This paper references
10.1016/S0161-6420(83)80010-4
Acquired immunodeficiency syndrome. Ophthalmic manifestations in ambulatory patients.
P. Rosenberg (1983)
10.1016/S0889-8588(18)30436-2
Hematologic abnormalities in AIDS.
D. Aboulafia (1991)
10.1172/JCI114230
Production of tumor necrosis factor alpha and interleukin 1 beta by monocytic cells infected with human immunodeficiency virus.
J. M. Molina (1989)
Acquired immunodeficiency syndrome. Distinctive features of bone marrow biopsies.
S. Geller (1985)
10.7326/0003-4819-107-4-502
Azidothymidine associated with bone marrow failure in the acquired immunodeficiency syndrome (AIDS).
P. Gill (1987)
10.1016/0002-9343(84)90695-8
Hematologic abnormalities in the acquired immune deficiency syndrome.
J. Spivak (1984)
10.1016/S0022-3476(05)82202-4
Chronic human parvovirus B19-induced erythroid hypoplasia as the initial manifestation of human immunodeficiency virus infection.
T. C. Griffin (1991)
10.1111/j.1749-6632.1991.tb17256.x
Effect of Human Immunodeficiency Virus Type 1 on CD34+ Cells a
G. Zauli (1991)
10.1093/AJCP/92.5.589
Bone marrow examination in patients with AIDS and AIDS-related complex (ARC). Morphologic and in situ hybridization studies.
N. Sun (1989)
10.1056/NEJM198409063111004
On the mechanism of thrombocytopenic purpura in sexually active homosexual men.
C. Walsh (1984)
10.1016/S0163-4453(88)93897-2
Disseminated Mycobacterium avium-intracellulare infection and red cell hypoplasia in patients with the acquired immune deficiency syndrome.
T. D. Gardener (1988)
The HIV-1 gp120 envelope protein has the intrinsic capacity to stimulate monokine secretion.
K. Clouse (1991)
10.1126/SCIENCE.2986290
Major glycoprotein antigens that induce antibodies in AIDS patients are encoded by HTLV-III.
J. Allan (1985)
10.1002/AJH.2830290207
Hematologic aspects of human immunodeficiency virus infection: Laboratory and clinical considerations
L. Perkocha (1988)
10.1056/NEJM198605083141912
Screening for lymphadenopathy/AIDS virus in bone marrow-transplant recipients.
E. Vilmer (1986)
10.1182/BLOOD.V76.2.317.BLOODJOURNAL762317
Human immunodeficiency virus infection of human bone marrow stromal fibroblasts.
D. Scadden (1991)
10.1182/BLOOD.V75.11.2137.BLOODJOURNAL75112137
Recombinant human granulocyte colony-stimulating factor increases circulating burst forming unit-erythron and red blood cell production in patients with severe human immunodeficiency virus infection.
S. Miles (1990)
10.1146/annurev.iy.03.040185.002401
Immunologic abnormalities in the acquired immunodeficiency syndrome.
H. Lane (1985)
10.1126/SCIENCE.1352911
Programmed death of T cells in HIV-1 infection.
L. Meyaard (1992)
Infection of human monocytes/macrophages by HIV-1: effect on secretion of IL-1 activity.
S. Roy (1988)
10.1182/BLOOD.V79.10.2680.2680
Impaired in vitro growth of purified (CD34+) hematopoietic progenitors in human immunodeficiency virus-1 seropositive thrombocytopenic individuals.
G. Zauli (1992)
10.7326/0003-4819-113-12-926
Persistent B19 parvovirus infection in patients infected with human immunodeficiency virus type 1 (HIV-1): a treatable cause of anemia in AIDS.
N. Frickhofen (1990)
10.1016/0090-1229(87)90180-2
Interleukin 1 inhibitor masks high interleukin 1 production in acquired immunodeficiency syndrome (AIDS).
M. Berman (1987)
10.1097/00002030-199111000-00010
Lack of compensatory megakaryocytopoiesis in HIV-1-seropositive thrombocytopenic individuals compared with immune thrombocytopenic purpura patients.
G. Zauli (1991)
10.1002/EJI.1830140614
Autoimmunity following viral infection: demonstration of monoclonal antibodies against normal tissue following infection of mice with reovirus and demonstration of shared antigenicity between virus and lymphocytes
M. Tardieu (1984)
10.1002/AJH.2830190206
Positive direct antiglobulin test associated with hyperglobulinemia in acquired immunodeficiency syndrome (AIDS)
P. Toy (1985)
10.1073/PNAS.87.21.8321
Transforming growth factor beta and noncytopathic mechanisms of immunodeficiency in human immunodeficiency virus infection.
J. Kekow (1990)
10.1126/SCIENCE.3047875
Cytokines alter production of HIV-1 from primary mononuclear phagocytes.
Y. Koyanagi (1988)
10.1016/0923-2516(90)90021-A
Pathophysiological mechanisms of HIV-induced defects in haematopoiesis: pathology of the bone marrow.
H. J. Stutte (1990)
10.1182/BLOOD.V77.10.2109.2109
Combined therapy with recombinant granulocyte colony-stimulating factor and erythropoietin decreases hematologic toxicity from zidovudine.
S. Miles (1991)
Induction of Monocytic Differentiation and NF-IcB-like Activities by Human Immtmodeficiency Virus 1 Infection of Myelomonoblastic Cells By Anne Roulston,*g 1 Mario D'Addario,*S 1 Francois Boulerice,*ll Stephen Caplan,~ll Mark A. Wainberg,*Sll82 and John Hiscott*Sil82
L. Davis (1992)
Interferon is the suppressor of hematopoiesis generated by stimulated lymphocytes in vitro.
N. Zoumbos (1984)
Determination of pharmacokinetics of replacement factor VIII.
P. Mannucci (1990)
10.7326/0003-4819-113-8-604
Antiretroviral Therapy in AIDS
S. Broder (1990)
10.1182/BLOOD.V78.7.1697.1697
Infection of megakaryocytes by human immunodeficiency virus in seropositive patients with immune thrombocytopenic purpura.
F. Louache (1991)
10.1016/1043-4666(91)90013-4
Biology of the RANTES/SIS cytokine family.
T. Schall (1991)
10.1128/JVI.65.4.1985-1990.1991
Absent or rare human immunodeficiency virus infection of bone marrow stem/progenitor cells in vivo.
B. Davis (1991)
10.1111/j.1365-2141.1987.tb06920.x
Incidence and mechanism of neutropenia and thrombocytopenia in patients with human immunodeficiency virus infection
M. Murphy (1987)
Peripheral blood and bone marrow abnormalities in the acquired immunodeficiency syndrome.
M. Frontiera (1987)
10.1182/BLOOD.V78.12.3200.BLOODJOURNAL78123200
Potential use of human stem cell factor as adjunctive therapy for human immunodeficiency virus-related cytopenias.
S. Miles (1991)
10.1126/SCIENCE.3313729
Cytokine-induced expression of HIV-1 in a chronically infected promonocyte cell line.
T. Folks (1987)
10.1126/SCIENCE.2502840
In vivo activity against HIV and favorable toxicity profile of 2',3'-dideoxyinosine.
R. Yarchoan (1989)
10.1046/j.1537-2995.1986.26587020112.x
Red cell autoantibodies in patients with acquired immune deficiency syndrome
M. McGinniss (1986)
10.1111/j.1365-2249.1992.tb06408.x
Anti‐neutrophil cytoplasmic autoantibodies in patients with symptomatic HIV infection
R. Klaassen (1992)
10.1111/j.1365-2141.1991.tb04443.x
Effects of recombinant human granulocyte colony‐stimulating factor on leucopenia in zidovudine‐treated patients with AIDS and AIDS related complex, a phase I/II study
P. A. van der Wouw (1991)
The suppressive influences of human tumor necrosis factors on bone marrow hematopoietic progenitor cells from normal donors and patients with leukemia: synergism of tumor necrosis factor and interferon-gamma.
H. Broxmeyer (1986)
10.1111/j.1365-2141.1985.tb02989.x
Anticardiolipin antibodies in autoimmune thrombocytopenic purpura
E. N. Harris (1985)
10.1172/JCI113831
Release of interleukin 1 inhibitory activity (contra-IL-1) by human monocyte-derived macrophages infected with human immunodeficiency virus in vitro and in vivo.
R. Locksley (1988)
10.1073/PNAS.88.19.8485
Interleukin 1 is processed and released during apoptosis.
K. Hogquist (1991)
Ifosfamide studies for primary or recurrent pediatric malignant solid tumors and leukemia.
C. Pratt (1990)
10.1111/j.1365-2141.1987.00261.x-i1
Peripheral blood and bone marrow abnormalities in patients with HIV related disease
M. Treacy (1987)
Clinical significance of HIV DNA in polymorphonuclear neutrophils from patients with HIV infection.
D. Gabrilovich (1993)
10.1084/JEM.175.3.751
Induction of monocytic differentiation and NF-kappa B-like activities by human immunodeficiency virus 1 infection of myelomonoblastic cells
A. Roulston (1992)
10.1084/JEM.172.4.1151
Human immunodeficiency virus type 1-infected individuals make autoantibodies that bind to CD43 on normal thymic lymphocytes
B. Ardman (1990)
Thrombocytopenia and human immunodeficiency virus-1 infection.
C. Walsh (1990)
HIV-1 infection and hematologic picture.
M. C. Re (1991)
Increased interferon-gamma and reduced hemoglobin in patients with human immunodeficiency virus type 1 infection.
D. Fuchs (1992)
10.1093/AJCP/84.4.425
The bone marrow in AIDS. A histologic, hematologic, and microbiologic study.
A. Castella (1985)
HIV induces IL-6 production by human B lymphocytes. Role of IL-4.
F. Boué (1992)
Effect of activated lymphocytes on the regulation of hematopoiesis: suppression of in vitro granulopoiesis by OKT8+Ia+T cells induced by alloantigen stimulation.
S. Nakao (1984)
10.1084/JEM.178.2.589
Autoimmune diabetes can be induced in transgenic major histocompatibility complex class II-deficient mice
T. Laufer (1993)
10.1172/JCI115337
Activation of human monocyte--derived macrophages with lipopolysaccharide decreases human immunodeficiency virus replication in vitro at the level of gene expression.
M. Bernstein (1991)
10.1182/BLOOD.V76.7.1281.BLOODJOURNAL7671281
CD34+ hematopoietic progenitor cells are not a major reservoir of the human immunodeficiency virus.
D. Laer (1990)
Recombinant gp120 specifically enhances tumor necrosis factor-alpha production and Ig secretion in B lymphocytes from HIV-infected individuals but not from seronegative donors.
P. Rieckmann (1991)
10.1126/SCIENCE.8235617
Multifactorial nature of human immunodeficiency virus disease: implications for therapy.
A. Fauci (1993)
10.1182/BLOOD.V80.6.1463.1463
Effect of human immunodeficiency virus-1 envelope glycoprotein on in vitro hematopoiesis of umbilical cord blood.
K. Sugiura (1992)
10.1111/j.1365-2141.1988.tb02454.x
Inhibition of bone marrow myelopoiesis and erythropoiesis in vitro by anti‐retroviral nucleoside derivatives
M. Johnson (1988)
10.1136/jcp.41.7.711
Haematological abnormalities in human immunodeficiency virus (HIV) disease.
C. Costello (1988)
10.3109/00313029009086664
Peripheral Blood and Bone Marrow Findings in Patients with Acquired Immune Deficiency Syndrome
C. E. Harris (1990)
10.1056/NEJM198511283132202
Target platelet antigen in homosexual men with immune thrombocytopenia.
R. Stricker (1985)
10.1038/312763A0
The CD4 (T4) antigen is an essential component of the receptor for the AIDS retrovirus
A. Dalgleish (1984)
10.1016/0268-960X(91)90037-D
Viruses and bone marrow failure.
N. Young (1984)
10.1111/j.1365-2141.1985.tb02988.x
Thrombocytopenia in SLE and related autoimmune disorders: association with anticardiolipin antibody
E. N. Harris (1985)
10.1182/BLOOD.V54.6.1376.BLOODJOURNAL5461376
T lymphocyte and monocyte-macrophage interaction in colony-stimulating activity elaboration in man.
Verma Ds (1979)
10.1016/0092-8674(87)90485-5
Detection of a fusion peptide sequence in the transmembrane protein of human immunodeficiency virus
W. Gallaher (1987)
10.1056/NEJM198311033091801
T-lymphocyte--mediated granulopoietic failure. In vitro identification of prednisone-responsive patients.
G. Bagby (1983)
10.1172/JCI115196
Association of circulating receptor Fc gamma RIII-positive monocytes in AIDS patients with elevated levels of transforming growth factor-beta.
J. Allen (1991)
10.1084/JEM.173.3.589
Transforming growth factor beta suppresses human immunodeficiency virus expression and replication in infected cells of the monocyte/macrophage lineage
G. Poli (1991)
10.1182/BLOOD.V78.12.3148.BLOODJOURNAL78123148
Recombinant human granulocyte-macrophage colony-stimulating factor ameliorates zidovudine-induced neutropenia in patients with acquired immunodeficiency syndrome (AIDS)/AIDS-related complex.
J. Levine (1991)
10.1093/AJCP/95.1.63
The bone marrow in human immunodeficiency virus (HIV)-related disease. Morphology and clinical correlation.
D. Karcher (1991)
10.1093/AJCP/87.6.780
Pneumocystis carinii involvement of the bone marrow in acquired immunodeficiency syndrome.
M. Heyman (1987)
10.7326/0003-4819-117-9-739
Recombinant human erythropoietin in the treatment of anemia associated with human immunodeficiency virus (HIV) infection and zidovudine therapy. Overview of four clinical trials.
D. Henry (1992)
10.1182/BLOOD.V77.8.1699.BLOODJOURNAL7781699
Macrophage-active colony-stimulating factors enhance human immunodeficiency virus type 1 infection in bone marrow stem cells.
K. Kitano (1991)
10.1099/0022-1317-73-2-417
Human immunodeficiency virus type 1 envelope glycoprotein gp120-mediated killing of human haematopoietic progenitors (CD34+ cells).
G. Zauli (1992)
10.1172/JCI112491
Infection of monocyte/macrophages by human T lymphotropic virus type III.
D. Ho (1986)
10.1016/0923-2516(90)90020-J
Changes in the haematopoietic progenitor cell compartment in the acquired immunodeficiency syndrome.
A. Ganser (1990)
10.1089/AID.1.1986.2.235
Hematologic correlates and the role of erythrocyte CR1 (C3b receptor) in the development of AIDS.
Y. Inada (1986)
10.1172/JCI113746
Downregulation of interferon alpha but not gamma receptor expression in vivo in the acquired immunodeficiency syndrome.
A. Lau (1988)
10.1111/j.1365-2141.1987.tb01307.x
Haematologic manifestations of the human immune deficiency virus (HIV)
L. Zon (1987)
10.1126/SCIENCE.1948066
Selective depletion in HIV infection of T cells that bear specific T cell receptor V beta sequences.
L. Imberti (1991)
10.1038/336200a0
Kinetochores on the move
T. Mitchison (1988)
10.1182/BLOOD.V70.5.1267.BLOODJOURNAL7051267
A glycoprotein inhibitor of in vitro granulopoiesis associated with AIDS.
Iz Leiderman (1987)
10.1111/j.1365-2141.1988.tb02455.x
Effects of type β transforming growth factors on haematopoietic progenitor cells
Masayuki Hino (1988)
10.1016/0167-5699(83)90015-4
This letter was sent to Dr Johnstone.
A. Johnstone (1983)
10.1073/PNAS.86.2.621
Human immunodeficiency virus glycoprotein (gp120) induction of monocyte arachidonic acid metabolites and interleukin 1.
L. Wahl (1989)
10.1016/0002-9343(91)90405-M
Treatment of AIDS with combinations of antiretroviral agents.
T. Merigan (1991)
10.1016/S0889-8588(18)30513-6
HIV-1-related thrombocytopenia.
S. Karpatkin (1990)
10.1016/0167-5699(91)90092-8
Cell dysfunction and depletion in AIDS: the programmed cell death hypothesis.
J. C. Ameisen (1991)
10.1084/JEM.175.2.331
Activation-induced death by apoptosis in CD4+ T cells from human immunodeficiency virus-infected asymptomatic individuals
H. Groux (1992)
10.1182/BLOOD.V63.4.729.BLOODJOURNAL634729
Viruses and bone marrow failure.
S. Rosenfeld (1991)
CD34+ bone marrow cells are infected with HIV in a subset of seropositive individuals.
S. Stanley (1992)
10.1016/0923-2516(91)90052-5
Infection of granulocyte/monocyte progenitor cells with HIV1.
G. Kojouharoff (1991)
10.7326/0003-4819-96-6-693
Disseminated Kaposi's sarcoma in homosexual men.
A. Friedman-Kien (1982)
10.1056/NEJM199205213262103
Detection of human immunodeficiency virus type 1 provirus in mononuclear cells by in situ polymerase chain reaction.
O. Bagasra (1992)
10.1182/BLOOD.V76.3.463.463
Subcutaneous recombinant granulocyte-macrophage colony-stimulating factor used as a single agent and in an alternating regimen with azidothymidine in leukopenic patients with severe human immunodeficiency virus infection.
J. Pluda (1990)
10.1111/J.1365-2141.1987.TB02304.X
Autoimmunity against blood cells in human immunodeficiency-virus (HIV) infection
J. Lelie (1987)
10.1038/326200A0
Suppression of in vitro haematopoiesis following human immunodeficiency virus infection
R. Donahue (1987)
10.1128/JVI.65.4.1765-1769.1991
In vitro suppression of normal human bone marrow progenitor cells by human immunodeficiency virus.
H. Steinberg (1991)
10.1016/S0889-8588(18)30437-4
Immunologic abnormalities in HIV infection.
K. Zunich (1991)
Induction of IL-6 (B cell stimulatory factor-2/IFN-beta 2) production by HIV.
K. Nakajima (1989)
10.1200/JCO.1991.9.5.802
Granulocyte-macrophage colony-stimulating factor mitigates the neutropenia of combined interferon alfa and zidovudine treatment of acquired immune deficiency syndrome-associated Kaposi's sarcoma.
D. Scadden (1991)
10.1172/JCI116294
Changes in interleukin-2 and interleukin-4 production in asymptomatic, human immunodeficiency virus-seropositive individuals.
M. Clerici (1993)
Spontaneous cytotoxicity and tumor necrosis factor production by peripheral blood monocytes from AIDS patients.
S. C. Wright (1988)
Inhibitory effect of azidothymidine, 2'-3'-dideoxyadenosine, and 2'-3'-dideoxycytidine on in vitro growth of hematopoietic progenitor cells from normal persons and from patients with AIDS.
A. Ganser (1989)
10.1172/JCI112595
Mechanisms of B cell activation in patients with acquired immunodeficiency syndrome and related disorders. Contribution of antibody-producing B cells, of Epstein-Barr virus-infected B cells, and of immunoglobulin production induced by human T cell lymphotropic virus, type III/lymphadenopathy-associa
R. Yarchoan (1986)
10.1038/clpt.1989.135
Basic concepts of hematopoiesis and the hematopoietic growth factors
E. Mazur (1989)
10.1126/SCIENCE.3016902
Direct polyclonal activation of human B lymphocytes by the acquired immune deficiency syndrome virus.
S. M. Schnittman (1986)
The effect of recombinant human granulocyte-macrophage colony-stimulating factor (rGM-CSF) on 3'-azido-3'-deoxythimidine (AZT)-mediated biochemical and cytotoxic effects on normal human myeloid progenitor cells
K. Bhalla (1989)
10.1200/JCO.1992.10.8.1344
Interferon-alpha, zidovudine, and granulocyte-macrophage colony-stimulating factor: a phase I AIDS Clinical Trials Group study in patients with Kaposi's sarcoma associated with AIDS.
S. Krown (1992)



This paper is referenced by
10.1002/stem.160079
An Intricate Web: Chemokine Receptors, HIV‐1 and Hematopoiesis
B. Lee (1998)
10.1016/S0889-8588(05)70390-7
Hematologic disorders and growth factor support in HIV infection.
D. Scadden (1996)
Growth and Development Factor Megakaryocyte Immunodeficiency Virus by Pegylated Recombinant Human Treatment of Thrombocytopenia in Chimpanzees Infected With Human
H. M. Mcclure (2013)
10.1371/journal.pctr.0020011
Haematological Safety of Perinatal Zidovudine in Pregnant HIV-1–Infected Women in Thailand: Secondary Analysis of a Randomized Trial
N. Briand (2007)
Stem Cells in Aging: Influence of Ontogenic, Genetic and Environmental Factors.
E. Yunis (2006)
10.1182/BLOOD.V90.12.4822.4822_4822_4831
Intracellular Immunization of Rhesus CD34+ Hematopoietic Progenitor Cells With a Hairpin Ribozyme Protects T Cells and Macrophages From Simian Immunodeficiency Virus Infection
M. L. Rosenzweig (1997)
10.32725/JAB.2008.017
Changes in CD 4+ cell count, lipid profile and liver enzymes in HIV infection and AIDS patients
P. Pasupathi (2008)
10.2741/PANOSKALTSIS
Human immunodeficiency virus and the hematopoietic repertoire: implications for gene therapy.
N. Panoskaltsis (1999)
ThyroidFunction,CardiacRiskAssessmentProfileand HematologicalChangesDuringHIVInfectionandAIDSPatients
Palanisamy Pasupathi (2010)
10.1046/j.1365-2141.1996.4801017.x
Macrophages are the major target cell for HIV infection in long‐term bone marrow culture and demonstrate dual susceptibility to lymphocytotropic and monocytotropic strains of HIV‐1
Vikki Gill (1996)
10.1002/(SICI)1096-8652(199811)59:3<238::AID-AJH10>3.0.CO;2-O
Infections affecting blood cell morphology
P. Phatak (1998)
10.1142/9789814295314_0001
The Role of Hematopoietic Progenitor Cells in Retroviral Pathogenesis
P. Banerjee (2010)
10.1111/J.1875-595X.1999.TB00531.X
Tooth extraction in HIV sero-positive patients.
P. Dios (1999)
10.1182/BLOOD.V93.6.1906.406K11_1906_1915
Human immunodeficiency virus type 1 Vpr alters bone marrow cell function.
J. Kulkosky (1999)
Influence of Ontogenic, Genetic and Environmental Factors
E. Yunis (2008)
10.5772/67596
Myelomonocytic Cell Lines in Modeling HIV-1 Infection of the Bone Marrow
Michael R. Nonnemacher (2017)
10.1089/088922202760265597
Suppression of clonogenic potential of human bone marrow mesenchymal stem cells by HIV type 1: putative role of HIV type 1 tat protein and inflammatory cytokines.
L. Wang (2002)
Use of hematopoietic hormones for bone marrow defects in AIDS.
D. Aboulafia (1997)
10.3329/JOM.V11I2.5455
Thyroid Function, Cardiac Risk Assessment Profile and Hematological Changes During HIV Infection and AIDS Patients
P. Pasupathi (2010)
10.1182/BLOOD.V91.3.907
Neither human immunodeficiency virus-1 (HIV-1) nor HIV-2 infects most- primitive human hematopoietic stem cells as assessed in long-term bone marrow cultures
F. Weichold (1998)
10.2741/1841
Setting the stage for bench-to-bedside movement of anti-HIV RNA inhibitors-gene therapy for AIDS in macaques.
S. E. Braun (2006)
10.1016/S0041-1345(98)01375-X
Successful treatment of autoimmune hemolytic anemia with intravenous immunoglobulin in a patient with AIDS.
C. A. González (1998)
10.5114/hivar.2019.88356
The relationship between self-reported physical activity level, haematological indices, and health-related quality of life of people living with human immunodeficiency virus
J. N. John (2019)
10.1080/09537104.2019.1689383
Platelet-endothelial associations may promote cytomegalovirus replication in the salivary gland in mice
Alicia M Braxton (2019)
10.4103/kleuhsj.kleuhsj_143_18
Human immunodeficiency virus-associated thrombocytopenia: Profiling hematological changes in the human immunodeficiency virus-infected and AIDS patients
Unnati Pitale (2018)
10.1182/BLOOD.V91.9.3239.3239_3239_3246
Ineffective platelet production in thrombocytopenic human immunodeficiency virus-infected patients.
J. L. Cole (1998)
10.1182/BLOOD.V91.12.4427.412K44_4427_4433
Treatment of thrombocytopenia in chimpanzees infected with human immunodeficiency virus by pegylated recombinant human megakaryocyte growth and development factor.
L. Harker (1998)
10.5958/2394-6792.2016.00050.8
Hematological outline in HIV infection in relation to CD4 cell count, a hospital based study
Hr Vanisri (2016)
10.1111/j.1538-7836.2006.01749.x
Lentivirus degradation and DC‐SIGN expression by human platelets and megakaryocytes
S. Boukour (2006)
10.1186/1471-2334-10-88
Parvovirus B19 infection and severe anaemia in Kenyan children: a retrospective case control study
J. Wildig (2010)
10.1007/978-1-4419-0793-6_5
HIV Latency and Reactivation: Role in Neuropathogenesis
Anupam Banerjee (2010)
10.1007/978-1-4899-0191-0_27
Growth Factors in the Treatment of HIV Disease
D. Scadden (1996)
See more
Semantic Scholar Logo Some data provided by SemanticScholar